InsiderClue
Stocks · Health care · Services-Commercial Physical & Biological Research

Medpace Holdings, Inc.

MEDP Clue Score73
United States Fiscal year ends December CIK 0001668397 Results filed 21 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

250
Insider
Date
Role
Action
Shares
Price
Amount
Stephen P Ewald
29 Oct 2026
General Counsel & Corp. Secy.
Sell
1,245
$690.00
$859.05K
Susan E Burwig
27 Oct 2026
Exec. VP, Operations
Sell
3,940
$677.00
$2.67M
Susan E Burwig
26 Oct 2026
Exec. VP, Operations
Sold after exercise
16,060
$677.00
$10.87M
Susan E Burwig
21 Oct 2026
Exec. VP, Operations
Exercised, kept
2,700
$166.73
$450.17K
Susan E Burwig
12 Oct 2026
Exec. VP, Operations
Exercised, kept
3,000
$166.73
$500.19K
Susan E Burwig
7 Oct 2026
Exec. VP, Operations
Exercised, kept
2,000
$166.73
$333.46K
August J. Troendle
30 Sep 2026
President & CEO
Sell
21,966
$625.47
$13.74M
August J. Troendle
29 Sep 2026
President & CEO
Sell
26,701
$621.02
$16.58M
August J. Troendle
28 Sep 2026
President & CEO
Sell
2,410
$620.07
$1.49M
August J. Troendle
25 Sep 2026
President & CEO
Sell
154
$620.60
$95.57K
August J. Troendle
24 Sep 2026
President & CEO
Sell
27,833
$621.33
$17.29M
August J. Troendle
23 Sep 2026
President & CEO
Sell
16,083
$628.64
$10.11M
August J. Troendle
22 Sep 2026
President & CEO
Sell
49,018
$628.11
$30.79M
August J. Troendle
21 Sep 2026
President & CEO
Sell
21,883
$623.29
$13.64M
August J. Troendle
17 Sep 2026
President & CEO
Sell
10,880
$620.40
$6.75M
August J. Troendle
16 Sep 2026
President & CEO
Sell
8,770
$621.29
$5.45M
August J. Troendle
15 Sep 2026
President & CEO
Sell
15,971
$620.84
$9.92M
Susan E Burwig
15 Sep 2026
Exec. VP, Operations
Exercised, kept
3,000
$166.73
$500.19K
August J. Troendle
27 Aug 2026
President & CEO
Sell
650
$620.27
$403.18K
Robert O. Kraft
26 Aug 2026
Director
Sold after exercise
3,858
$617.81
$2.38M
August J. Troendle
26 Aug 2026
President & CEO
Sell
4,000
$620.03
$2.48M
August J. Troendle
25 Aug 2026
President & CEO
Sell
673
$620.38
$417.52K
August J. Troendle
24 Aug 2026
President & CEO
Sell
1,983
$620.23
$1.23M
August J. Troendle
21 Aug 2026
President & CEO
Sell
13,995
$624.45
$8.74M
Kevin M. Brady
20 Aug 2026
CFO & Treasurer
Sold after exercise
3,400
$625.24
$2.13M
August J. Troendle
20 Aug 2026
President & CEO
Sell
27,174
$618.79
$16.81M
Fred B Davenport Jr
19 Aug 2026
Director
Sold after exercise
7,283
$606.15
$4.41M
Brian T Carley
19 Aug 2026
Director
Sell
5,000
$608.63
$3.04M
August J. Troendle
19 Aug 2026
President & CEO
Sell
15,609
$606.47
$9.47M
August J. Troendle
13 Aug 2026
President & CEO
Sell
458
$600.39
$274.98K
August J. Troendle
12 Aug 2026
President & CEO
Sell
11,366
$601.53
$6.84M
August J. Troendle
11 Aug 2026
President & CEO
Sell
17,610
$605.11
$10.66M
Cornelius P. McCarthy III
11 Aug 2026
Director
Sell
1,140
$605.37
$690.12K
August J. Troendle
10 Aug 2026
President & CEO
Sell
5,534
$601.53
$3.33M
Cornelius P. McCarthy III
7 Aug 2026
Director
Sold after exercise
795
$585.07
$465.13K
Susan E Burwig
28 Jul 2026
Exec. VP, Operations
Sell
7,500
$600.00
$4.50M
August J. Troendle
28 Jul 2026
President & CEO
Sell
3,510
$600.01
$2.11M
August J. Troendle
27 Jul 2026
President & CEO
Sell
3,728
$600.85
$2.24M
Stephen P Ewald
28 May 2026
General Counsel & Corp. Secy.
Sold after exercise
16,349
$450.00
$7.36M
Kevin M. Brady
24 Apr 2026
CFO & Treasurer
Exercised, kept
7,000
$138.87
$972.09K
Stephen P Ewald
24 Apr 2026
General Counsel & Corp. Secy.
Exercised, kept
3,500
$138.87
$486.05K
Susan E Burwig
18 Mar 2026
Exec. VP, Operations
Exercised, kept
12,000
$166.73
$2.00M
Jesse J Geiger
17 Mar 2026
President
Sold after exercise
31,707
$455.30
$14.44M
Stephen P Ewald
17 Feb 2026
General Counsel & Corp. Secy.
Exercised, kept
3,500
$138.87
$486.05K
Susan E Burwig
13 Feb 2026
Exec. VP, Operations
Exercised, kept
10,984
$107.93
$1.19M
Brian T Carley
13 Feb 2026
Director
Exercised, kept
6,472
$54.99
$355.90K
Susan E Burwig
5 Dec 2025
Exec. VP, Operations
Exercised, kept
10,000
$107.93
$1.08M
August J. Troendle
3 Dec 2025
CEO
Sell
668
$590.69
$394.58K
August J. Troendle
2 Dec 2025
CEO
Sell
5,698
$590.47
$3.36M
Susan E Burwig
2 Dec 2025
Exec. VP, Operations
Exercised, kept
10,000
$107.93
$1.08M
August J. Troendle
1 Dec 2025
CEO
Sell
23,178
$593.25
$13.75M
August J. Troendle
28 Nov 2025
CEO
Sell
15,151
$593.46
$8.99M
August J. Troendle
26 Nov 2025
CEO
Sell
41,331
$606.88
$25.08M
August J. Troendle
25 Nov 2025
CEO
Sell
42,392
$615.52
$26.09M
Susan E Burwig
24 Nov 2025
Exec. VP, Operations
Sell
20,000
$609.15
$12.18M
August J. Troendle
24 Nov 2025
CEO
Sell
59,025
$607.78
$35.87M
August J. Troendle
21 Nov 2025
CEO
Sell
21,858
$592.18
$12.94M
Kevin M. Brady
21 Nov 2025
CFO & Treasurer
Sold after exercise
3,000
$590.35
$1.77M
August J. Troendle
20 Nov 2025
CEO
Sell
6,830
$598.49
$4.09M
August J. Troendle
19 Nov 2025
CEO
Sell
23,862
$592.07
$14.13M
August J. Troendle
18 Nov 2025
CEO
Sell
7,191
$590.84
$4.25M
August J. Troendle
17 Nov 2025
CEO
Sell
6,047
$591.00
$3.57M
August J. Troendle
14 Nov 2025
CEO
Sell
14,747
$595.26
$8.78M
Robert O. Kraft
14 Nov 2025
Director
Sold after exercise
6,472
$591.85
$3.83M
August J. Troendle
13 Nov 2025
CEO
Sell
5,128
$601.37
$3.08M
August J. Troendle
12 Nov 2025
CEO
Sell
5,312
$603.23
$3.20M
Susan E Burwig
11 Nov 2025
Exec. VP, Operations
Sell
18,000
$605.00
$10.89M
Jesse J Geiger
5 Nov 2025
President
Sold on a plan
21,503
$595.66
$12.81M
Fred B Davenport Jr
30 Oct 2025
Director
Sold after exercise
5,972
$581.88
$3.47M
Jesse J Geiger
29 Oct 2025
President
Sold after exercise
3,568
$585.00
$2.09M
Susan E Burwig
27 Oct 2025
Exec. VP, Operations
Sell
2,000
$605.01
$1.21M
Stephen P Ewald
27 Oct 2025
General Counsel & Corp. Secy.
Sold after exercise
15,230
$598.85
$9.12M
Jesse J Geiger
27 Oct 2025
President
Sold after exercise
19,460
$605.12
$11.78M
Susan E Burwig
26 Sep 2025
Exec. VP, Operations
Exercised, kept
10,000
$107.93
$1.08M
Susan E Burwig
3 Sep 2025
Exec. VP, Operations
Sell
10,000
$480.00
$4.80M
August J. Troendle
2 Sep 2025
CEO
Sell
1,197
$475.11
$568.71K
August J. Troendle
29 Aug 2025
CEO
Sell
36,196
$475.90
$17.23M
August J. Troendle
27 Aug 2025
CEO
Sell
620
$475.00
$294.50K
Susan E Burwig
26 Aug 2025
Exec. VP, Operations
Exercised, kept
10,000
$107.93
$1.08M
Cornelius P. McCarthy III
19 Aug 2025
Director
Sell
1,662
$465.04
$772.90K
August J. Troendle
28 Jul 2025
CEO
Sell
48,487
$451.69
$21.90M
Susan E Burwig
28 Jul 2025
Exec. VP, Operations
Sell
7,500
$450.14
$3.38M
Stephen P Ewald
28 Jul 2025
General Counsel & Corp. Secy.
Sell
3,000
$450.00
$1.35M
Kevin M. Brady
24 Jul 2025
CFO & Treasurer
Sold after exercise
12,000
$454.23
$5.45M
Jesse J Geiger
24 Jul 2025
President
Sold after exercise
41,801
$453.11
$18.94M
Cornelius P. McCarthy III
22 Jul 2025
Director
Exercised, kept
1,972
$54.99
$108.44K
Cornelius P. McCarthy III
18 Jul 2025
Director
Exercised, kept
4,500
$54.99
$247.46K
Fred B Davenport Jr
24 Apr 2025
Director
Sold after exercise
1,712
$301.82
$516.72K
August J. Troendle
7 Mar 2025
CEO
Exercised, kept
84,770
$107.93
$9.15M
August J. Troendle
7 Mar 2025
CEO
Exercised, kept
234,259
$56.61
$13.26M
August J. Troendle
7 Mar 2025
CEO
Exercised, kept
37,417
$54.74
$2.05M
Stephen P Ewald
27 Feb 2025
General Counsel & Corp. Secy.
Buy
2
$326.11
$652.22
Brian T Carley
24 Feb 2025
Director
Sold after exercise
4,003
$345.59
$1.38M
Jesse J Geiger
6 Dec 2024
President
Exercised, kept
15,000
$32.05
$480.75K
Susan E Burwig
19 Nov 2024
Exec. VP, Operations
Exercised, kept
7,500
$32.05
$240.38K
Robert O. Kraft
23 Aug 2024
Director
Sold after exercise
3,774
$390.73
$1.47M
Robert O. Kraft
22 Aug 2024
Director
Sold after exercise
4,353
$390.73
$1.70M
Susan E Burwig
5 Aug 2024
Exec. VP, Operations
Exercised, kept
50,000
$90.65
$4.53M
Susan E Burwig
5 Jun 2024
Exec. VP, Operations
Sell
7,681
$401.20
$3.08M
August J. Troendle
28 May 2024
CEO
Sell
5,695
$395.49
$2.25M
August J. Troendle
24 May 2024
CEO
Sell
3,987
$395.22
$1.58M
August J. Troendle
22 May 2024
CEO
Sell
55
$400.00
$22.00K
August J. Troendle
20 May 2024
CEO
Sell
4,020
$400.19
$1.61M
August J. Troendle
16 May 2024
CEO
Sell
7,060
$403.09
$2.85M
August J. Troendle
15 May 2024
CEO
Sell
32,282
$405.13
$13.08M
August J. Troendle
10 May 2024
CEO
Sell
4,956
$402.89
$2.00M
August J. Troendle
9 May 2024
CEO
Sell
3,486
$400.17
$1.39M
August J. Troendle
8 May 2024
CEO
Sell
4,782
$400.58
$1.92M
August J. Troendle
7 May 2024
CEO
Sell
28,032
$404.48
$11.34M
August J. Troendle
6 May 2024
CEO
Sell
24,372
$401.73
$9.79M
August J. Troendle
2 May 2024
CEO
Sell
3,396
$400.44
$1.36M
August J. Troendle
1 May 2024
CEO
Sell
12,934
$401.56
$5.19M
August J. Troendle
30 Apr 2024
CEO
Sell
1,828
$400.31
$731.77K
August J. Troendle
29 Apr 2024
CEO
Sell
15,102
$400.69
$6.05M
Susan E Burwig
15 Mar 2024
Exec. VP, Operations
Sell
102
$403.00
$41.11K
Ashley M. Keating
14 Mar 2024
Director
Sold after exercise
250
$409.87
$102.47K
Medpace Investors, LLC
8 Mar 2024
10% owner
Sell
25,000
$408.71
$10.22M
August J. Troendle
8 Mar 2024
CEO
Sell indirect
25,000
$408.71
$10.22M
Ashley M. Keating
7 Mar 2024
Director
Sold after exercise
472
$415.00
$195.88K
Medpace Investors, LLC
7 Mar 2024
10% owner
Sell
75,000
$410.74
$30.81M
August J. Troendle
7 Mar 2024
CEO
Sell indirect
75,000
$410.74
$30.81M
Medpace Investors, LLC
6 Mar 2024
10% owner
Sell
100,000
$412.98
$41.30M
August J. Troendle
6 Mar 2024
CEO
Sell indirect
100,000
$412.98
$41.30M
Medpace Investors, LLC
5 Mar 2024
10% owner
Sell
50,000
$402.70
$20.14M
August J. Troendle
5 Mar 2024
CEO
Sell indirect
50,000
$402.70
$20.14M
Jesse J Geiger
5 Mar 2024
President
Exercised, kept
17,679
$90.65
$1.60M
Medpace Investors, LLC
4 Mar 2024
10% owner
Sell
50,000
$403.12
$20.16M
August J. Troendle
4 Mar 2024
CEO
Sell indirect
50,000
$403.12
$20.16M
Jesse J Geiger
4 Mar 2024
President
Sold after exercise
22,321
$403.03
$9.00M
Stephen P Ewald
1 Mar 2024
General Counsel & Corp. Secy.
Sell
350
$400.79
$140.28K
August J. Troendle
1 Mar 2024
CEO
Sell indirect
80,000
$401.88
$32.15M
Medpace Investors, LLC
1 Mar 2024
10% owner
Sell
80,000
$401.88
$32.15M
Jesse J Geiger
29 Feb 2024
President
Sell
2,558
$393.51
$1.01M
Stephen P Ewald
29 Feb 2024
General Counsel & Corp. Secy.
Sell
1,163
$393.51
$457.65K
August J. Troendle
29 Feb 2024
CEO
Sell indirect
20,000
$393.71
$7.87M
Medpace Investors, LLC
29 Feb 2024
10% owner
Sell
20,000
$393.71
$7.87M
Medpace Investors, LLC
28 Feb 2024
10% owner
Sell
50,000
$404.13
$20.21M
August J. Troendle
28 Feb 2024
CEO
Sell indirect
50,000
$404.13
$20.21M
Ashley M. Keating
28 Feb 2024
Director
Sold after exercise
500
$405.00
$202.50K
Medpace Investors, LLC
27 Feb 2024
10% owner
Sell
50,000
$401.88
$20.09M
August J. Troendle
27 Feb 2024
CEO
Sell indirect
50,000
$401.88
$20.09M
Medpace Investors, LLC
26 Feb 2024
10% owner
Sell
56,928
$402.38
$22.91M
August J. Troendle
26 Feb 2024
CEO
Sell indirect
56,928
$402.38
$22.91M
Ashley M. Keating
26 Feb 2024
Director
Sold after exercise
254
$404.68
$102.79K
Ashley M. Keating
26 Feb 2024
Director
Sold after exercise
246
$403.89
$99.36K
Medpace Investors, LLC
23 Feb 2024
10% owner
Sell
100,000
$400.32
$40.03M
August J. Troendle
23 Feb 2024
CEO
Sell indirect
100,000
$400.32
$40.03M
August J. Troendle
22 Feb 2024
CEO
Sell indirect
100,000
$395.98
$39.60M
Medpace Investors, LLC
22 Feb 2024
10% owner
Sell
100,000
$395.98
$39.60M
August J. Troendle
21 Feb 2024
CEO
Sell indirect
36,012
$383.44
$13.81M
Medpace Investors, LLC
21 Feb 2024
10% owner
Sell
36,012
$383.44
$13.81M
August J. Troendle
20 Feb 2024
CEO
Sell indirect
13,988
$386.39
$5.40M
Medpace Investors, LLC
20 Feb 2024
10% owner
Sell
13,988
$386.39
$5.40M
Brian T Carley
20 Feb 2024
Director
Exercised, kept
13,782
$26.44
$364.40K
August J. Troendle
16 Feb 2024
CEO
Sell indirect
50,000
$391.75
$19.59M
Medpace Investors, LLC
16 Feb 2024
10% owner
Sell
50,000
$391.75
$19.59M
Cornelius P. McCarthy III
8 Feb 2024
Director
Exercised, kept
4,710
$57.17
$269.27K
Susan E Burwig
15 Dec 2023
Exec. VP, Operations
Sell
2,009
$303.00
$608.73K
Susan E Burwig
14 Dec 2023
Exec. VP, Operations
Sell
10,391
$304.15
$3.16M
Medpace Investors, LLC
1 Dec 2023
10% owner
Sell
24,039
$273.26
$6.57M
August J. Troendle
1 Dec 2023
CEO
Sell indirect
24,039
$273.26
$6.57M
Medpace Investors, LLC
30 Nov 2023
10% owner
Sell
7,871
$272.18
$2.14M
August J. Troendle
30 Nov 2023
CEO
Sell indirect
7,871
$272.18
$2.14M
Medpace Investors, LLC
29 Nov 2023
10% owner
Sell
18,090
$272.62
$4.93M
Medpace Investors, LLC
29 Nov 2023
10% owner
Sell
3,167
$272.87
$864.18K
August J. Troendle
29 Nov 2023
CEO
Sell indirect
18,090
$272.62
$4.93M
August J. Troendle
29 Nov 2023
CEO
Sell indirect
3,167
$272.87
$864.18K
August J. Troendle
28 Nov 2023
CEO
Sell indirect
21,833
$273.66
$5.97M
Medpace Investors, LLC
28 Nov 2023
10% owner
Sell
21,833
$273.66
$5.97M
August J. Troendle
27 Nov 2023
CEO
Sell indirect
25,000
$276.10
$6.90M
Medpace Investors, LLC
27 Nov 2023
10% owner
Sell
25,000
$276.10
$6.90M
Medpace Investors, LLC
22 Nov 2023
10% owner
Sell
25,000
$277.81
$6.95M
August J. Troendle
22 Nov 2023
CEO
Sell indirect
25,000
$277.81
$6.95M
August J. Troendle
21 Nov 2023
CEO
Sell indirect
25,000
$277.37
$6.93M
Medpace Investors, LLC
21 Nov 2023
10% owner
Sell
25,000
$277.37
$6.93M
August J. Troendle
20 Nov 2023
CEO
Sell indirect
50,000
$275.45
$13.77M
Medpace Investors, LLC
20 Nov 2023
10% owner
Sell
50,000
$275.45
$13.77M
August J. Troendle
17 Nov 2023
CEO
Sell indirect
50,000
$273.91
$13.70M
Medpace Investors, LLC
17 Nov 2023
10% owner
Sell
50,000
$273.91
$13.70M
Medpace Investors, LLC
16 Nov 2023
10% owner
Sell
17,000
$281.61
$4.79M
August J. Troendle
16 Nov 2023
CEO
Sell indirect
17,000
$281.61
$4.79M
Medpace Investors, LLC
15 Nov 2023
10% owner
Sell
33,000
$283.42
$9.35M
August J. Troendle
15 Nov 2023
CEO
Sell indirect
33,000
$283.42
$9.35M
Medpace Investors, LLC
14 Nov 2023
10% owner
Sell
25,000
$283.11
$7.08M
August J. Troendle
14 Nov 2023
CEO
Sell indirect
25,000
$283.11
$7.08M
Susan E Burwig
23 Oct 2023
Exec. VP, Operations
Exercised, kept
7,500
$32.05
$240.38K
Medpace Investors, LLC
21 Sep 2023
10% owner
Sold on a plan
61,655
$244.27
$15.06M
August J. Troendle
21 Sep 2023
CEO
Sold on a plan indirect
61,655
$244.27
$15.06M
Medpace Investors, LLC
20 Sep 2023
10% owner
Sold on a plan
65,653
$255.48
$16.77M
August J. Troendle
20 Sep 2023
CEO
Sold on a plan indirect
65,653
$255.48
$16.77M
August J. Troendle
19 Sep 2023
CEO
Sold on a plan indirect
137,379
$259.66
$35.67M
Medpace Investors, LLC
19 Sep 2023
10% owner
Sold on a plan
137,379
$259.66
$35.67M
August J. Troendle
18 Sep 2023
CEO
Sold on a plan indirect
53,385
$274.76
$14.67M
Medpace Investors, LLC
18 Sep 2023
10% owner
Sold on a plan
53,385
$274.76
$14.67M
Robert O. Kraft
14 Aug 2023
Director
Sold after exercise
13,782
$265.67
$3.66M
Kevin M. Brady
31 Jul 2023
CFO & Treasurer
Sold after exercise
7,000
$255.00
$1.79M
Stephen P Ewald
27 Jul 2023
General Counsel & Corp. Secy.
Sold after exercise
21,850
$254.39
$5.56M
Brian T Carley
15 Jun 2023
Director
Exercised, kept
7,400
$23.00
$170.20K
Medpace Investors, LLC
8 Jun 2023
10% owner
Sold on a plan
49,347
$220.85
$10.90M
August J. Troendle
8 Jun 2023
CEO
Sold on a plan indirect
49,347
$220.85
$10.90M
Medpace Investors, LLC
7 Jun 2023
10% owner
Sold on a plan
110,324
$223.05
$24.61M
August J. Troendle
7 Jun 2023
CEO
Sold on a plan indirect
110,324
$223.05
$24.61M
Medpace Investors, LLC
6 Jun 2023
10% owner
Sold on a plan
58,681
$220.46
$12.94M
August J. Troendle
6 Jun 2023
CEO
Sold on a plan indirect
58,681
$220.46
$12.94M
Medpace Investors, LLC
25 Apr 2023
10% owner
Sold on a plan
31,648
$221.83
$7.02M
August J. Troendle
25 Apr 2023
CEO
Sold on a plan indirect
31,648
$221.83
$7.02M
Kevin M. Brady
16 Nov 2022
CFO & Treasurer
Sell
344
$227.09
$78.12K
Jesse J Geiger
15 Nov 2022
President
Sold after exercise
7,000
$230.00
$1.61M
Kevin M. Brady
15 Nov 2022
CFO & Treasurer
Sell
1,656
$229.30
$379.72K
Robert O. Kraft
1 Nov 2022
Director
Sold after exercise
9,630
$221.42
$2.13M
Stephen P Ewald
27 Oct 2022
General Counsel & Corp. Secy.
Sold after exercise
6,500
$220.53
$1.43M
August J. Troendle
22 Sep 2022
CEO
Buy indirect
57,426
$154.59
$8.88M
Medpace Investors, LLC
22 Sep 2022
10% owner
Buy
57,426
$154.59
$8.88M
Medpace Investors, LLC
21 Sep 2022
10% owner
Buy
94,119
$161.63
$15.21M
August J. Troendle
21 Sep 2022
CEO
Buy indirect
94,119
$161.63
$15.21M
Medpace Investors, LLC
20 Sep 2022
10% owner
Buy
94,119
$155.14
$14.60M
August J. Troendle
20 Sep 2022
CEO
Buy indirect
94,119
$155.14
$14.60M
August J. Troendle
19 Sep 2022
CEO
Buy indirect
94,119
$153.48
$14.45M
Medpace Investors, LLC
19 Sep 2022
10% owner
Buy
94,119
$153.48
$14.45M
August J. Troendle
16 Sep 2022
CEO
Buy indirect
62,516
$149.58
$9.35M
Medpace Investors, LLC
16 Sep 2022
10% owner
Buy
62,516
$149.58
$9.35M
Medpace Investors, LLC
15 Sep 2022
10% owner
Buy
62,516
$153.11
$9.57M
August J. Troendle
15 Sep 2022
CEO
Buy indirect
62,516
$153.11
$9.57M
Medpace Investors, LLC
14 Sep 2022
10% owner
Buy
62,516
$152.66
$9.54M
August J. Troendle
14 Sep 2022
CEO
Buy indirect
62,516
$152.66
$9.54M
Medpace Investors, LLC
13 Sep 2022
10% owner
Buy
62,516
$157.12
$9.82M
August J. Troendle
13 Sep 2022
CEO
Buy indirect
62,516
$157.12
$9.82M
Medpace Investors, LLC
12 Sep 2022
10% owner
Buy
62,515
$167.58
$10.48M
August J. Troendle
12 Sep 2022
CEO
Buy indirect
62,515
$167.58
$10.48M
Medpace Investors, LLC
9 Sep 2022
10% owner
Buy
56,557
$164.33
$9.29M
August J. Troendle
9 Sep 2022
CEO
Buy indirect
56,557
$164.33
$9.29M
Medpace Investors, LLC
8 Sep 2022
10% owner
Buy
56,557
$157.65
$8.92M
August J. Troendle
8 Sep 2022
CEO
Buy indirect
56,557
$157.65
$8.92M
August J. Troendle
7 Sep 2022
CEO
Buy indirect
56,557
$150.72
$8.52M
Medpace Investors, LLC
7 Sep 2022
10% owner
Buy
56,557
$150.72
$8.52M
August J. Troendle
6 Sep 2022
CEO
Buy indirect
56,557
$147.59
$8.35M
Medpace Investors, LLC
6 Sep 2022
10% owner
Buy
56,557
$147.59
$8.35M
August J. Troendle
2 Sep 2022
CEO
Buy indirect
48,714
$144.98
$7.06M
Medpace Investors, LLC
2 Sep 2022
10% owner
Buy
48,714
$144.98
$7.06M
August J. Troendle
1 Sep 2022
CEO
Buy indirect
42,076
$144.52
$6.08M
Medpace Investors, LLC
1 Sep 2022
10% owner
Buy
42,076
$144.52
$6.08M
Medpace Investors, LLC
18 Jul 2022
10% owner
Buy
8,330
$145.00
$1.21M
August J. Troendle
18 Jul 2022
CEO
Buy indirect
8,330
$145.00
$1.21M
Medpace Investors, LLC
14 Jul 2022
10% owner
Buy
22,290
$144.59
$3.22M
August J. Troendle
14 Jul 2022
CEO
Buy indirect
22,290
$144.59
$3.22M
Stephen P Ewald
6 May 2022
General Counsel & Corp. Secy.
Exercised, kept
1,000
$32.05
$32.05K
August J. Troendle
1 Mar 2022
CEO
Exercised, kept
100,000
$90.65
$9.07M
Susan E Burwig
23 Feb 2022
Exec. VP, Operations
Exercised, kept
12,400
$28.32
$351.17K
Fred B Davenport Jr
17 Feb 2022
Director
Buy indirect
500
$145.80
$72.90K
Medpace Investors, LLC
4 Jan 2022
10% owner
Sell
3,338
$213.44
$712.46K
Showing 250 of 621 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 535
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 53
Sales at will 444
Transactions with no price 0
Shares from compensation/vesting 26,772,951
Sales filed before the plan box existed 311
History held since 12 Aug 2016